Prelude Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $142k | 30k | 4.74 |
| 2023-12-31 | $414k | 97k | 4.27 |
| 2023-09-30 | $932k | 302k | 3.09 |
| 2023-06-30 | $174k | 39k | 4.50 |
| 2022-12-31 | $111k | 18k | 6.04 |
| 2022-06-30 | $2.1M | 407k | 5.22 |
| 2022-03-31 | $1.5M | 222k | 6.92 |
| 2021-12-31 | $1.7M | 139k | 12.45 |
| 2021-09-30 | $453k | 15k | 31.25 |
| 2021-03-31 | $843k | 20k | 43.25 |
| 2020-09-30 | $3.3M | 111k | 30.12 |